therapeutic discovery and development

Cogentis Therapeutics is a biotechnology company based in Columbia, Maryland, that discovers and develops first-in-class therapeutics to prevent neurodegeneration and restore brain function. It is committed to finding cures for neurodegenerative diseases including Alzheimer's disease, frontotemporal dementia, Parkinson's disease, and amyotrophic lateral sclerosis (ALS).

Read more

neuroscience research